Skip to main content
Erschienen in: Israel Journal of Health Policy Research 1/2020

Open Access 01.12.2020 | Original research article

Community Vs. hospital HIV testing sites in Jerusalem, Israel - who’s tested and who’s at risk?

verfasst von: Dor Atias, Hagai Levine, Hila Elinav, Michele Haouzi-Bashan, Yotam Lior, Zohar Mor

Erschienen in: Israel Journal of Health Policy Research | Ausgabe 1/2020

Abstract

Background

After decades of constant increase in HIV diagnoses among men who have sex with men (MSM), a gradual decrease has been reported in recent years. Timely detection of HIV leads to early treatment and behavioral changes which decrease further transmissions. This cross-sectional study aimed to assess demographic and behavioral characteristics of individuals who were tested for HIV in Jerusalem, Israel.

Methods

This study compared individuals who were tested at Hadassah AIDS Center (HAC) with those tested at the Jerusalem Open House (JOH) - an LGBTQ community center. Participants completed anonymous questionnaires regarding their demographic, HIV-testing history, and sexual behaviors. High-risk sexual behavior (HRSB) was defined as a diagnosis of sexually transmitted disease or condomless anal/vaginal sex during the last year.

Results

Among 863 participants, 104 (12.1%) were tested in HAC and 759 (87.9%) in JOH. Of those, 19 (18.3%) and 227 (29.9%) were HRSB, respectively. Two MSM were tested positive in JOH. JOH received more MSM, HRSB and individuals who were previously tested for HIV, while HAC received more migrants and health-care workers. HRSB-participants were more commonly younger, males, non-Jewish, with lower income, previously tested for HIV, reported more sexual partners, payed for sex or used drugs.

Conclusions

MSM and HRSB-individuals were more likely to be tested in JOH, while migrants and health-care workers in HAC, possibly due to the geographic location, reputation and specific atmosphere. In order to encourage HIV-tests among HRSB and non-Jews, additional interventions should be employed, including outreach activities, extending opening hours and reducing testing costs should be employed.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s13584-020-00368-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AIDS
Acquired immunodeficiency syndrome
ART
Antiretroviral therapy
HAC
Hadassah AIDS Center in Hadassah hospital
HIV
Human immunodeficiency virus
HRSB
High-risk sexual behavior
JOH
Jerusalem Open House for Pride and Tolerance
LGBTQ
Lesbian, Gay, Bisexual, Transgender, and Queer
MOH
Israeli ministry of health
MSM
Men who have sex with men
NGO
Non-governmental organization
PrEP
Pre-exposure prophylaxis
STD
Sexually transmitted disease
UNAIDS
The Joint United Nations Program on HIV/AIDS

Background

After more than two decades of constant increase in HIV diagnoses among men who have sex with men (MSM), a gradual decrease has been reported in recent years both in Europe and Israel [13]. Yet, the burden of disease among MSM remains high and recent reports estimated that the proportion of MSM among all men infected with HIV in Israel to be as high as 41% [4]. Several behavioral characteristics are associated with the high proportion of HIV among MSM, including AIDS optimism, the use of recreational drugs during sex- which is colloquially termed as Chemsex, and the increasing use of geographical network applications to seek sexual partners [5]. As a response to the burden of HIV, MSM and other key risk groups for HIV infection are encouraged to use condoms and recommended to test periodically for HIV. Additional innovative strategies include the use of pre-exposure prophylaxis (PrEP) in selected cases and encouraging people who are living with HIV/AIDS to increase their adherence to the antiretroviral therapy (ART) [6].
Early HIV detection through periodic HIV testing enables infected individuals to use ART at early stages of their infection and therefore to suppress their viral load and decrease the risk for further HIV transmission [7, 8]. The Joint United Nations Program on HIV/AIDS (UNAIDS) set a goal in December 2013 to reach that 90% of people who are HIV infected will be diagnosed, 90% of people who are diagnosed will be on ART and 90% of those who receive ART will be virally suppressed, which is conceptualized as the 90–90-90 cascade [9].
Confidential HIV tests in Israel are performed free of charge by primary care physicians, community organizations or the AIDS centers in general hospitals. Individuals who are interested in anonymous testing can attend one of the seven AIDS centers distributed throughout Israel or any of the few testing sites operated by a non-governmental organization (NGO) in the community, located in Tel-Aviv, Jerusalem and Haifa. NGO community testing sites are often characterized by a friendly, non-stigmatizing atmosphere and are mostly operated by peers from the key risk groups themselves. An Israeli study performed 20 years ago showed that individuals from key risk groups prefer to be tested at community testing sites rather than in a hospital setting [10].
The Jerusalem district comprised of over 1 million inhabitants, 66.5% of them are Jewish, 30.7% Muslims, 1.5% Christians and 1.3% are undefined [11]. Two HIV testing sites are certified and regulated by the Israeli ministry of health (MOH) in Jerusalem. The first is the Hadassah AIDS center at Hadassah hospital (HAC), which is located outside of the city center and operates once a week by nurses and doctors during the morning hours. The second is the Open clinic at the Jerusalem Open House for Pride and Tolerance (JOH), an NGO based testing site located in the city center. It is operated by peers from the Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) community and offers HIV testing once weekly in the evening hours. While both centers offered free HIV testing, they differ in their protocol of operation. At HAC, only anonymous testing require payment, while at JOH all testing required payment until July 2018 and were offered free of charge since then.
As these two testing centers in Jerusalem are different in their operating procedures and ambiance, this study aimed to compare the demographic characteristics, sexual behaviors and testing results of individuals who were tested in JOH and HAC and characterize the high-risk sexual behavior among individuals who are tested for HIV in Jerusalem. Results from this study can be used by NGOs and the MOH to target populations at risk and appropriate testing infrastructure for the needs and preferences of the targeted populations.

Methods

This cross-sectional study was performed in two testing sites in Jerusalem, the JOH and HAC, between October 2017 and November 2018. All individuals older than 14 years of age who visited the testing these sites were requested to complete the anonymous study questionnaire. Participants were asked to indicate their demographic details regarding their sex, age, religion, city of residence, income, level of education, as well as their sexual preferences and behaviors, substances use, history of HIV testing and the reason for the current test. Independent variables for this study included high-risk sexual behavior (HRSB) and the choice for a specific HIV testing site - either JOH or HAC. The definition of HRSB was aligned with the indications set by the Centers for Diseases Control and Prevention for PrEP use [12], which included prior diagnoses of sexually transmitted disease (STD) in the last year and/or whether they were MSM and performed condomless sex in the last year, or were heterosexuals and performed anal or vaginal condomless sex in the last year with a person at risk for HIV transmission. Person at risk for HIV transmission included MSM, immigrants from Africa and intravenous drug users.

Statistical analysis

Participants who were tested in JOH were compared with those who were tested in HAC, and participants who were involved in HRSB in the last year were compared with those at low risk. Continuous variables were compared by the Student’s t-test if normally distributed, while the Mann Whitey non-parametric test was performed in other cases. Categorical variables were compared by the chi-square test or Fisher exact test when the number of variables in the cells was less than five. Variables that reached statistical significance lesser than 5% in the univariate analysis were included in the multivariate analyses performed by logistic regression model after exclusion of variable interactions to associate demographic and behavioral characteristics of individuals who prefer to get tested at the JOH.

Results

During the study period, 244 individuals were tested in HAC and 775 in the JOH. Of those, 104 (42.6%) and 759 (97.9%) completed the study questionnaire, respectively. The average age of all 863 participants who completed the questionnaire was 30.4 ± 10.8 years and the majority (81.8%) were males. Two individuals (0.3%) were tested positive for HIV in JOH, both were MSM, living in Jerusalem, underwent previous HIV tests and reported infrequent condom use during sex. They did not report prior STD diagnosis, nor did they pay for sex or preformed sex under the influence of drugs during the past year.
Individuals who were tested at the JOH had a higher level of education and were more likely to be previously tested for HIV than individuals who were tested in HAC (Table 1). JOH had higher proportion of MSM and likely to engage in HRSB, HAC had higher proportion of migrants from Africa. Individuals who were tested in JOH indicated that the reason for choosing the testing site was the atmosphere at the JOH (although results did not reach statistical significance), while those tested at HAC more commonly indicated the credibility of the site, which is situated in the hospital.
Table 1
Demographic and behavioral characteristics of individuals tested in the JOHaVs. the HACb
Variable (number of responders)
JOHan = 759 (87.9%)
HACbn = 104 (12.1%)
P
Mean age (±standard deviation)
30.3 ± 10.8
31.3 ± 10.5
0.4
Male sex (n = 863)
622 (81.9)
78 (75.0)
0.09
None Jew (n = 647)
96 (17.7)
14 (13.5)
0.3
Living outside of Jerusalem (n = 863)
54 (7.1)
9 (8.7)
0.6
Above high-school education (n = 590)
360 (72.7)
58 (61.1)
0.02
Income higher than the average salary (n = 552)
94 (20.6)
15 (15.8)
0.3
Prior HIV test (n = 852)
531 (70.9)
56 (54.4)
0.001
Risk groups (n = 863)
MSMc
390 (51.4)
22 (21.2)
< 0.001
Immigrants from African countries
4 (0.5)
9 (8.7)
< 0.001
Sex workers
2 (0.3)
0 (0.0)
1.0
Intravenous drug users
3 (0.4)
0 (0.0)
1.000
Partners of people from risk groups
32 (4.2)
4 (3.8)
1.0
Not belonging to any key risk group
328 (43.2)
69 (66.3)
< 0.001
High risk (n = 863)
227 (29.9)
19 (18.3)
0.01
Reason for testing (n = 863)
Condomless sex
378 (49.8)
48 (46.2)
0.5
New relationship
104 (13.7)
15 (14.4)
0.8
Routine test
203 (26.7)
20 (19.2)
0.1
Occupational exposure
2 (0.3)
6 (5.8)
< 0.001
Intra venous drug use
0 (0.0)
1 (1.0)
0.1
Paid for sex
11 (1.4)
0 (0.0)
0.4
Other low-risk reasons for testing
15 (2.0)
6 (5.8)
0.03
Reasons for choosing the testing center (n = 862)
Easy access
369 (48.6)
54 (52.4)
0.5
Rapid tests available
216 (28.5)
27 (26.2)
0.6
Credibility
147 (19.4)
39 (37.9)
< 0.001
Atmosphere
143 (18.8)
12 (11.7)
0.07
Recommendations from friends
133 (17.5)
13 (12.6)
0.2
Cost
52 (6.9)
6 (5.8)
0.7
Not associated with any population
65 (8.6)
8 (7.8)
0.8
Positive HIV results (n = 759)
2 (0.3)
0 (0.0)
1.000
aJOH – Jerusalem Open House for Pride and tolerance
bHAC – Hadassah AIDS center
cMSM – Men who have Sex with Men
In the multivariate analysis (Table 2), higher levels of education and being MSM were associated with choosing JOH as a testing site for HIV, while being a migrant from Africa or being at a lower sexual risk for HIV transmission were negatively associated with JOH. In our study, 246 (28.5%) participants were involved in HRSB during the last year. They were found to be more commonly younger, males, non-Jewish, living outside of Jerusalem, had lower income and were previously tested for HIV compared with those who reported low sexual risk for HIV transmission (Table 3). Individuals involved in HRSB also reported a greater number of sexual partners, were more likely to pay for sex, performed sex under the influence of recreational drugs and were tested because they performed condomless sex compared with individuals who were at a low risk for HIV transmission.
Table 2
Variables predicting testing for HIV at JOHa
Variable
Odds ratio
95% Confidence Interval
P
Above high-school education
1.7
1.1–2.7
0.04
Prior HIV test
1.2
0.7–1.9
0.4
Risk Group – MSMb
3.1
1.7–5.5
< 0.001
Risk Group - Immigrants from African countries
0.1
0.02–0.5
0.006
Reason for testing – other low-risk reason
0.3
0.1–1.1
0.07
High-risk sexual behavior
1.0
0.5–1.9
0.9
aJOH Jerusalem Open House for Pride and tolerance
bMSM Men who have Sex with Men
Table 3
Demographic and behavioral characteristics of high-risk Vs. low-risk participants
Variable (number of responders)
High risk n = 246 (28.5%)
Low risk n = 617 (71.5%)
P
Mean age (±standard deviation)
28.4 ± 11.2
31.2 ± 10.6
0.001
Male sex (n = 863)
228 (92.7)
472 (76.5)
< 0.001
None Jew (n = 647)
47 (25.7)
63 (13.6)
< 0.001
Living outside of Jerusalem (n = 863)
26 (10.6)
37 (6.0)
0.02
Above high-school education (n = 590)
116 (67.1)
302 (72.4)
0.2
Income higher than the average salary (n = 552)
21 (13.3)
88 (22.3)
0.02
Prior HIV test (n = 852)
186 (76.5)
401 (65.8)
0.002
Sexual behavior in the last year
More than 15 sexual partners (n = 715)
22 (11.2)
23 (4.4)
0.001
Paid for sex (n = 793)
19 (8.1)
25 (4.5)
0.04
Having sex under the influence of psychoactive drugs (n = 803)
89 (36.8)
157 (28.0)
0.01
Reason for testing (n = 863)
Condomless sex
167 (67.9)
259 (42.0)
< 0.001
New relationship
21 (8.5)
98 (15.9)
0.005
Routine test
48 (19.5)
175 (28.4)
0.007
Occupational exposure
0 (0.0)
8 (1.3)
0.1
Intra venous drug use
0 (0.0)
1 (0.2)
1.0
Paid for sex
3 (1.2)
8 (1.3)
1.0
Other low-risk reasons for testing
2 (0.8)
19 (3.1)
0.05
Reasons for choosing the testing center (n = 862)
Easy access
125 (50.8)
298 (48.4)
0.5
Rapid tests available
57 (23.2)
186 (30.2)
0.04
Credibility
55 (22.4)
131 (21.3)
0.7
Atmosphere
42 (17.1)
113 (18.3)
0.7
Recommendations from friends
44 (17.9)
102 (16.6)
0.6
Cost
17 (6.9)
41 (6.7)
0.9
Not associated with any population
19 (7.7)
54 (8.8)
0.6
Positive HIV results (n = 759)
2 (0.8)
0 (0.0)
0.08

Discussion

This study indicated that individuals who were tested at the JOH were more commonly MSM and involved in HRSB, while two (0.3%) were detected with HIV, both were MSM. Those who were tested in HAC were more commonly migrants and their sexual behavior was at lower risk compared with those tested at the JOH.
MSM and individuals who reported HRSB were more likely to be tested in community-based testing center rather than testing sites which are situated in hospital, in agreement with findings from other studies from Israel and other countries [10, 13, 14]. These preferences can be attributed to two main factors. First, the JOH functions as an LGBTQ community center, which provides additional services for MSM, such as public events, psychological treatments, and social support. It operates by LGBTQ peers and provides a friendly and non-stigmatized space for sexual minorities. The non-stigmatizing atmosphere is effective in improving the access to health care among the LGBTQ community who may face stigmatization or discomfort while interacting with health care workers [15, 16]. Second, the JOH is geographically situated in the city center, while the HAC do not offer HIV testing after working hours and is located in a suburb of the city which is relatively difficult to access.
The HAC testing site captured different populations than JOH, such as health care workers who were tested following occupational exposures in the hospital and migrants from African. Participants in our study rated the HAC as having higher credibility than the JOH, which is attributed to the nature of a hospital setting. The HAC employs Ethiopian health worker who supports the migrants and provides linguistic translation and cultural adaptation, in addition to translated printed materials in Amharic which are available at this site. Other publications have also demonstrated the association between the capability of a testing center to respond to the cultural and linguistic barriers of the migrants which are associated with patient-physician relationship, increase the frequency of testing and supporting prevention interventions [1719].
The HIV prevalence among the HRSB population in our study was 0.8%, which correlates with the current estimations of HIV prevalence among MSM in Israel [20]. However, compared with previous studies performed in an STD clinic in Tel-Aviv, we have found a lower proportion of HRSB among the study participants, such as previous STD diagnoses, purchasing sex and condomless sex [2123]. It might be that MSM at high risk in Jerusalem were tested in other places, like Tel Aviv, or that the JOH did not capture them. The cost of HIV tests which was required at the JOH until July 2018 might also discouraged HRSB individuals with lower income to be tested in JOH.
The proportion of non-Jewish individuals in our study was lower than their actual proportion in the Jerusalem district (17.0 and 33.5%, respectively) [11], although relatively higher proportion of non-Jews were involved in HRSB. A recent study performed in Israel found that Arab MSM demonstrated inferior knowledge regarding HIV transmission compared with Jewish MSM. The same study also demonstrated that Arabs were more likely than Jews to engage in HRSB [24]. This underrepresentation of Arabs who were tested for HIV should be addressed by both HIV testing centers in Jerusalem while taking into consideration that non-Jewish MSM in Jerusalem may be more traditional and ‘closeted’ in comparison with the Jewish population, and therefore more difficult to reach.
As shown in our study, socio-cultural adaptations of testing sites increase the centers accessibility to target populations. Therefore, we recommend the Jerusalem testing sites to continue developing culturally competent interventions to enhance HIV testing among MSM and individuals who practice HRSB, as well as among non-Jewish individuals and immigrants from African countries. This can be achieved by reducing possible clinic-related barriers for testing for example, expanding working hours, offering free HIV tests and providing anonymous and rapid testing [25, 26]. Advertising the centers services could be useful in attracting hard to reach population. This can be achieved by outreach activities in gay-related venues and immigrant centers or by promoting the clinic’s services via geosocial networking smartphone applications which are frequently used by MSM to seek their sexual encounters [27, 28]. Lastly, as a response to the increasing rates of STDs and the prevalence of HIV-STDs co-infection [2931], we also recommend expanding the HIV testing centers to provide a complete STD panel, anonymously and affordably.
This is the first study to assess HIV-testing sites in Jerusalem, yet, it is subject to several limitations. First, information bias is possible, as participants may be uncomfortable to share their sexual experiences. To reduce this bias, the questionnaires were completed anonymously. Second, due to the different intake protocols between JOH and HAC, response rates between the centers were different. At JOH, completion of the questionnaire was part of the routine intake at the clinic, while in the HAC the questionnaires were offered to the individuals in addition to other registration procedures, therefore the compliance in HAC was lower and might have resulted in selection bias. To assess the possible bias, we compared the age and sex of the HAC testees who participated in the study with the total population that was tested in HAC in the same period. Individuals who participated in the study were younger (31.2 versus 35.1 years, p = 0.01) and more commonly male (75.0% versus 65.0%, p = 0.07). This selection bias is therefore conservative, as older individuals and females are probably engaging in lower sexual risk behavior [32]. Third, the difference in HIV testing costs and procedural change practiced at JOH in July 2018 limits the investigators to assess the association between the cost and the adherence to HIV testing. To assess the effect of the policy change on the composition of JOH population, we compared those who were tested prior and after the pricing policy change. No significant difference in age, sex, religion and risk score were found (Additional file 1). Forth, PrEP has been approved for use in Israel during the study period and requires HIV testing before administration at their family physicians. This policy change could have potentially shifted HRSB individuals from NGO testing sites to the community clinics, a move that may have resulted in underrepresentation of the HRSB population, and therefore the selection bias, if exists, is conservative.

Conclusions

Higher proportion of MSM and those who performed HRSB were tested at the JOH, while migrants were more likely to be tested at HAC. Social and cultural adaptations of the testing site are effective in capturing population at high risk for HIV transmission. In order to improve HIV prevention programs in Jerusalem, both centers should facilitate out-reach interventions aiming HRSB individuals and the non-Jewish population.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s13584-020-00368-3.

Acknowledgments

This author thanks to the staffs of the Israeli AIDS Task Force, the Jerusalem Open House and the Hadassah AIDS center who helped in the establishment of the questionnaire and data collection throughout the study period.

Ethics approval

The study was approved by the Institutional Review Board of Hadassah hospital (HMO-17-0027) and the Ministry of Health (MOH-170-2016).
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Mor Z, Weinstein R, Grotto I, Levin Y, Chemtob D. Thirty years of HIV in Israel: current epidemiology and future challenges. BMJ Open. 2013;3(7):e003078.CrossRef Mor Z, Weinstein R, Grotto I, Levin Y, Chemtob D. Thirty years of HIV in Israel: current epidemiology and future challenges. BMJ Open. 2013;3(7):e003078.CrossRef
2.
Zurück zum Zitat European Centre for Disease Prevention and Control WROfE. HIV/AIDS surveillance in Europe 2018–2017 data. Copenhagen: WHO Regional Office for Europe. European Centre for Disease Prevention and Control, WHO Regional Office for Europe; 2018. European Centre for Disease Prevention and Control WROfE. HIV/AIDS surveillance in Europe 2018–2017 data. Copenhagen: WHO Regional Office for Europe. European Centre for Disease Prevention and Control, WHO Regional Office for Europe; 2018.
3.
Zurück zum Zitat Chemtob D. HIV HIV/AIDS in Israel : Periodic Epidemiological Report 1981–2018. Jerusalem: Ministry Of Health; 2019. Chemtob D. HIV HIV/AIDS in Israel : Periodic Epidemiological Report 1981–2018. Jerusalem: Ministry Of Health; 2019.
4.
Zurück zum Zitat Chemtob D, Mor Z, Harel N, Averick N. HIV infection among men who have sex with men in Israel: a 35-year epidemiological and clinical overview, 1981-2015. BMC Public Health. 2019;19(1):747.CrossRef Chemtob D, Mor Z, Harel N, Averick N. HIV infection among men who have sex with men in Israel: a 35-year epidemiological and clinical overview, 1981-2015. BMC Public Health. 2019;19(1):747.CrossRef
5.
Zurück zum Zitat Mor Z, Dan M. The HIV epidemic among men who have sex with men--behaviour beats science. EMBO Rep. 2012;13(11):948–53.CrossRef Mor Z, Dan M. The HIV epidemic among men who have sex with men--behaviour beats science. EMBO Rep. 2012;13(11):948–53.CrossRef
7.
Zurück zum Zitat Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–e47.CrossRef Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–e47.CrossRef
8.
Zurück zum Zitat Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive PARTNER taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189). Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive PARTNER taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189).
9.
Zurück zum Zitat HIV/AIDS JUNPo, HIV/Aids JUNPo. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: Unaids; 2014. HIV/AIDS JUNPo, HIV/Aids JUNPo. 90–90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: Unaids; 2014.
10.
Zurück zum Zitat Levi I, Modan B, Blumstein T, Luxenburg O, Yehuda-Cohen T, Shasha B, et al. Characteristics of clients attending confidential versus anonymous testing clinics for human immunodeficiency virus. Isr Med Assoc J. 2001;3(3):184–7.PubMed Levi I, Modan B, Blumstein T, Luxenburg O, Yehuda-Cohen T, Shasha B, et al. Characteristics of clients attending confidential versus anonymous testing clinics for human immunodeficiency virus. Isr Med Assoc J. 2001;3(3):184–7.PubMed
11.
Zurück zum Zitat Central Bureau of Statistics. Statistical Abstract of Israel 2018- No.69. Jerusalem: Central Bureau of Statistics; 2018. Central Bureau of Statistics. Statistical Abstract of Israel 2018- No.69. Jerusalem: Central Bureau of Statistics; 2018.
12.
Zurück zum Zitat Prevention CfDCa, Service UPH. Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. CDC: Atlanta; 2018. Prevention CfDCa, Service UPH. Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. CDC: Atlanta; 2018.
13.
Zurück zum Zitat Yang M, Prestage G, Maycock B, Brown G, de Wit J, McKechnie M, et al. The acceptability of different HIV testing approaches: cross-sectional study among GMSM in Australia. Sex Transm Infect. 2014;90(8):592–5.CrossRef Yang M, Prestage G, Maycock B, Brown G, de Wit J, McKechnie M, et al. The acceptability of different HIV testing approaches: cross-sectional study among GMSM in Australia. Sex Transm Infect. 2014;90(8):592–5.CrossRef
14.
Zurück zum Zitat Smith LV, Rudy ET, Javanbakht M, Uniyal A, Sy LS, Horton T, et al. Client satisfaction with rapid HIV testing: comparison between an urban sexually transmitted disease clinic and a community-based testing center. AIDS Patient Care STDs. 2006;20(10):693–700.CrossRef Smith LV, Rudy ET, Javanbakht M, Uniyal A, Sy LS, Horton T, et al. Client satisfaction with rapid HIV testing: comparison between an urban sexually transmitted disease clinic and a community-based testing center. AIDS Patient Care STDs. 2006;20(10):693–700.CrossRef
15.
Zurück zum Zitat Mayer KH, Bradford JB, Makadon HJ, Stall R, Goldhammer H, Landers S. Sexual and gender minority health: what we know and what needs to be done. Am J Public Health. 2008;98(6):989–95.CrossRef Mayer KH, Bradford JB, Makadon HJ, Stall R, Goldhammer H, Landers S. Sexual and gender minority health: what we know and what needs to be done. Am J Public Health. 2008;98(6):989–95.CrossRef
16.
Zurück zum Zitat Leshin D, Olshtain-Pops K, Moses A, Elinav H. Limited awareness of the effective timing of HIV post-exposure prophylaxis among people with high-risk exposure to HIV. Eur J Clin Microbiol Infect Dis. 2019;38(4):779–84.CrossRef Leshin D, Olshtain-Pops K, Moses A, Elinav H. Limited awareness of the effective timing of HIV post-exposure prophylaxis among people with high-risk exposure to HIV. Eur J Clin Microbiol Infect Dis. 2019;38(4):779–84.CrossRef
17.
Zurück zum Zitat Majumdar B, Browne G, Roberts J, Carpio B. Effects of cultural sensitivity training on health care provider attitudes and patient outcomes. J Nurs Scholarsh. 2004;36(2):161–6.CrossRef Majumdar B, Browne G, Roberts J, Carpio B. Effects of cultural sensitivity training on health care provider attitudes and patient outcomes. J Nurs Scholarsh. 2004;36(2):161–6.CrossRef
18.
Zurück zum Zitat Tucker CM, Herman KC, Pedersen TR, Higley B, Montrichard M, Ivery P. Cultural sensitivity in physician-patient relationships: perspectives of an ethnically diverse sample of low-income primary care patients. Med Care. 2003;41(7):859–70.CrossRef Tucker CM, Herman KC, Pedersen TR, Higley B, Montrichard M, Ivery P. Cultural sensitivity in physician-patient relationships: perspectives of an ethnically diverse sample of low-income primary care patients. Med Care. 2003;41(7):859–70.CrossRef
19.
Zurück zum Zitat Bucharski D, Reutter LI, Ogilvie LD. “you need to know where we're coming from”: Canadian aboriginal women's perspectives on culturally appropriate HIV counseling and testing. Health Care Women Int. 2006;27(8):723–47.CrossRef Bucharski D, Reutter LI, Ogilvie LD. “you need to know where we're coming from”: Canadian aboriginal women's perspectives on culturally appropriate HIV counseling and testing. Health Care Women Int. 2006;27(8):723–47.CrossRef
20.
Zurück zum Zitat Mor Z, Davidovich U. Same-sex sexual attraction, behavior, and practices of Jewish men in Israel and the association with HIV prevalence. AIDS Care. 2016;28(Sup1):64–7.CrossRef Mor Z, Davidovich U. Same-sex sexual attraction, behavior, and practices of Jewish men in Israel and the association with HIV prevalence. AIDS Care. 2016;28(Sup1):64–7.CrossRef
21.
Zurück zum Zitat Rich R, Leventhal A, Sheffer R, Mor Z. Heterosexual men who purchase sex and attended an STI clinic in Israel: characteristics and sexual behavior. Isr J Health Policy Res. 2018;7(1):19.CrossRef Rich R, Leventhal A, Sheffer R, Mor Z. Heterosexual men who purchase sex and attended an STI clinic in Israel: characteristics and sexual behavior. Isr J Health Policy Res. 2018;7(1):19.CrossRef
22.
Zurück zum Zitat Mor Z, Shohat T, Goor Y, Dan M. Risk behaviors and sexually transmitted diseases in gay and heterosexual men attending an STD clinic in Tel Aviv, Israel: a cross-sectional study. Isr Med Assoc J. 2012;14(3):147–51.PubMed Mor Z, Shohat T, Goor Y, Dan M. Risk behaviors and sexually transmitted diseases in gay and heterosexual men attending an STD clinic in Tel Aviv, Israel: a cross-sectional study. Isr Med Assoc J. 2012;14(3):147–51.PubMed
23.
Zurück zum Zitat Rich RS, Leventhal A, Sheffer R, Mor Z. Risky sexual behavior and sexually transmitted infections among men who have sex with men and purchase sex attending an Israeli sexually transmitted infection clinic. Int J STD AIDS. 2019;956462419830856:236–43.CrossRef Rich RS, Leventhal A, Sheffer R, Mor Z. Risky sexual behavior and sexually transmitted infections among men who have sex with men and purchase sex attending an Israeli sexually transmitted infection clinic. Int J STD AIDS. 2019;956462419830856:236–43.CrossRef
24.
Zurück zum Zitat Mor Z, Grayeb E, Beany A. Arab men who have sex with men in Israel: knowledge, attitudes and sexual practices. HIV Med. 2016;17(4):298–304.CrossRef Mor Z, Grayeb E, Beany A. Arab men who have sex with men in Israel: knowledge, attitudes and sexual practices. HIV Med. 2016;17(4):298–304.CrossRef
25.
Zurück zum Zitat Persson KI, Berglund T, Bergström J, Eriksson LE, Tikkanen R, Thorson A, et al. Motivators and barriers for HIV testing among men who have sex with men in Sweden. J Clin Nurs. 2016;25(23-24).CrossRef Persson KI, Berglund T, Bergström J, Eriksson LE, Tikkanen R, Thorson A, et al. Motivators and barriers for HIV testing among men who have sex with men in Sweden. J Clin Nurs. 2016;25(23-24).CrossRef
26.
Zurück zum Zitat Pharr JR, Lough NL, Ezeanolue EE. Barriers to HIV testing among young men who have sex with men (MSM): experiences from Clark County, Nevada. Glob J Health Sci. 2015;8(7):9–17.CrossRef Pharr JR, Lough NL, Ezeanolue EE. Barriers to HIV testing among young men who have sex with men (MSM): experiences from Clark County, Nevada. Glob J Health Sci. 2015;8(7):9–17.CrossRef
27.
Zurück zum Zitat Fernández-Balbuena S, de la Fuente L, Hoyos J, Rosales-Statkus ME, Barrio G, Belza MJ, et al. Highly visible street-based HIV rapid testing: is it an attractive option for a previously untested population? A cross-sectional study. Sex Transm Infect. 2014;90(2):112–8.CrossRef Fernández-Balbuena S, de la Fuente L, Hoyos J, Rosales-Statkus ME, Barrio G, Belza MJ, et al. Highly visible street-based HIV rapid testing: is it an attractive option for a previously untested population? A cross-sectional study. Sex Transm Infect. 2014;90(2):112–8.CrossRef
28.
Zurück zum Zitat Cao B, Gupta S, Wang J, Hightow-Weidman LB, Muessig KE, Tang W, et al. Social media interventions to promote HIV testing, linkage, adherence, and retention: systematic review and meta-analysis. J Med Internet Res. 2017;19(11):e394.CrossRef Cao B, Gupta S, Wang J, Hightow-Weidman LB, Muessig KE, Tang W, et al. Social media interventions to promote HIV testing, linkage, adherence, and retention: systematic review and meta-analysis. J Med Internet Res. 2017;19(11):e394.CrossRef
29.
Zurück zum Zitat Chen MJ, Scheer S, Nguyen TQ, Kohn RP, Schwarcz SK. HIV Coinfection among persons diagnosed as having sexually transmitted diseases, San Francisco, 2007 to 2014. Sex Transm Dis. 2018;45(8):563–72.CrossRef Chen MJ, Scheer S, Nguyen TQ, Kohn RP, Schwarcz SK. HIV Coinfection among persons diagnosed as having sexually transmitted diseases, San Francisco, 2007 to 2014. Sex Transm Dis. 2018;45(8):563–72.CrossRef
30.
Zurück zum Zitat Polansky A, Levy I, Mor Z. Risk factors of syphilis co-infection among HIV. AIDS Care. 2019;31(9):1157–61.CrossRef Polansky A, Levy I, Mor Z. Risk factors of syphilis co-infection among HIV. AIDS Care. 2019;31(9):1157–61.CrossRef
31.
Zurück zum Zitat Braxton J, Davis DW, Emerson B, Flagg EW, Grey J, Grier L, et al. Sexually transmitted disease surveillance 2017. 2018.CrossRef Braxton J, Davis DW, Emerson B, Flagg EW, Grey J, Grier L, et al. Sexually transmitted disease surveillance 2017. 2018.CrossRef
32.
Zurück zum Zitat Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001;358(9296):1835–42.CrossRef Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001;358(9296):1835–42.CrossRef
Metadaten
Titel
Community Vs. hospital HIV testing sites in Jerusalem, Israel - who’s tested and who’s at risk?
verfasst von
Dor Atias
Hagai Levine
Hila Elinav
Michele Haouzi-Bashan
Yotam Lior
Zohar Mor
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Israel Journal of Health Policy Research / Ausgabe 1/2020
Elektronische ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-020-00368-3

Weitere Artikel der Ausgabe 1/2020

Israel Journal of Health Policy Research 1/2020 Zur Ausgabe